Literature DB >> 16104986

Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years.

E Diza1, F Frantzidou, E Souliou, M Arvanitidou, G Gioula, A Antoniadis.   

Abstract

The seroprevalence of Toxoplasma gondii in the northern Greek population was determined in 1984, 1994 and 2004, and changes during this period were investigated. In total, 1014, 812 and 958 sera from individuals aged 1 day to 70 years were examined in 1984, 1994 and 2004, respectively, for IgG and IgM anti-Toxoplasma antibodies with the standard immunofluorescence assay (IFA) and microparticle enzyme immunoassay (MEIA). In individuals positive for IgM-specific antibodies, primary infection with Toxoplasma was diagnosed on the basis of the Toxoplasma serological profile (IFA, MEIA, conventional IgM and IgA ELISAs, immunosorbent agglutination assay and IgG avidity test). The prevalence of IgG-specific antibodies in the general population was 37%, 29.9% and 24.1% in 1984, 1994 and 2004, respectively, and was 35.6%, 25.6% and 20%, respectively, in women of reproductive age (15-39 years). The incidence of Toxoplasma infection, based on cases of primary infection and the annual seroconversion rate for the general population, was estimated to be 1.25% and 1.1% in 1984, 1.05% and 0.93% in 1994, and 0.85% and 0.8% in 2004. The significant decline in prevalence, and the shift towards an older age group, observed during this period could be explained by the improved socio-economic situation. The high (80%) proportion of women of reproductive age susceptible to Toxoplasma infection, with an estimated 90-200 neonates infected in utero annually, seems to present a potential risk to public health. Education of the public and prophylactic measures may become increasingly important.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16104986     DOI: 10.1111/j.1469-0691.2005.01193.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  12 in total

Review 1.  Kinetics of Toxoplasma infection in the Balkans.

Authors:  Branko Bobić; Aleksandra Nikolić; Ivana Klun; Olgica Djurković-Djaković
Journal:  Wien Klin Wochenschr       Date:  2011-09-22       Impact factor: 1.704

2.  Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell's palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy.

Authors:  Maria Riga; G Kefalidis; A Chatzimoschou; G Tripsianis; S Kartali; H Gouveris; M Katotomichelakis; V Danielides
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-09       Impact factor: 2.503

3.  Risk-based estimate of effect of foodborne diseases on public health, Greece.

Authors:  Elissavet Gkogka; Martine W Reij; Arie H Havelaar; Marcel H Zwietering; Leon G M Gorris
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

4.  Seroepidemiology and risk factors of Toxoplasma gondii infection in undergraduate university female students in Jordan.

Authors:  M M Obaidat; N A Al-Sheyab; A E Bani Salman; S Q Lafi
Journal:  Epidemiol Infect       Date:  2014-12-29       Impact factor: 4.434

5.  Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades.

Authors:  Maria João Gargaté; Idalina Ferreira; Anabela Vilares; Susana Martins; Carlos Cardoso; Susana Silva; Baltazar Nunes; João Paulo Gomes
Journal:  BMJ Open       Date:  2016-10-05       Impact factor: 2.692

6.  Neospora caninum and/or Toxoplasma gondii Seroprevalence: Vaccination against PCV2 and Muscle Enzyme Activity in Seropositive and Seronegative Pigs.

Authors:  Labrini V Athanasiou; Vasileios G Papatsiros; Victoria M Spanou; Eleni G Katsogiannou; Anna Dedousi
Journal:  Microorganisms       Date:  2021-05-20

7.  A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy.

Authors:  M Mosti; B Pinto; A Giromella; S Fabiani; R Cristofani; M Panichi; F Bruschi
Journal:  Epidemiol Infect       Date:  2012-12-11       Impact factor: 4.434

8.  Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar.

Authors:  Marawan A Abu-Madi; Naema Al-Molawi; Jerzy M Behnke
Journal:  Parasit Vectors       Date:  2008-10-20       Impact factor: 3.876

9.  Case report of a neonate with ocular toxoplasmosis due to congenital infection: estimation of the percentage of ocular toxoplasmosis in Greece caused by congenital or acquired infection.

Authors:  Ioannis Asproudis; Ioannis Koumpoulis; Chris Kalogeropoulos; Georgios Sotiropoulos; Margarita Papassava; Miltiadis Aspiotis
Journal:  Clin Ophthalmol       Date:  2013-11-21

10.  Human Parasitic Diseases in Bulgaria in Between 2013-2014.

Authors:  Iskra Rainova; Rumen Harizanov; Iskren Kaftandjiev; Nina Tsvetkova; Ognyan Mikov; Eleonora Kaneva
Journal:  Balkan Med J       Date:  2017-09-13       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.